Kimberley J. Evason, MD, PhD joined the University of Utah in January 2016 as an Assistant Professor in the Department of Pathology and an Investigator at the Huntsman Cancer Institute in the Department of Oncological Sciences.  Kim is a physician-scientist whose research and clinical interests are centered on gastrointestinal (GI) and liver pathology.  She is particularly interested in hepatocellular carcinoma (HCC), the most common type of malignant tumor that originates in the liver and a leading cause of cancer-related death. One reason HCC is particularly deadly is the lack of effective treatments, especially for advanced disease, which is when most tumors are diagnosed. Kim’s research focuses on investigating molecular pathways and identifying drugs that influence liver tumorigenesis.  Kim uses a variety of experimental approaches including zebrafish models. Kim completed the Medical Scientist Training Program (MD/PhD) at Washington University in St. Louis in 2007.  She did residency and fellowship training in anatomic and liver/GI pathology at UCSF, followed by a post-doctoral fellowship, mentored by Didier Stainier, Andrei Goga, and J. Michael Bishop.

Oncological Sciences, Pathology, cancer